NEW YORK, May 15 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products in China, today released the following statement regarding the earthquake in China:
"Our thoughts are with the many victims of China's earthquake and we are thankful to report that none of our staff was hurt in the tragic events. Our manufacturing, production and overall operations were not impacted by the earthquake and we do not anticipate any damage-related impact to our sales in the second quarter," stated Mr. Tony Liu, Chairman and Chief Executive Officer of American Oriental Bioengineering.
About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China. For more information, visit http://www.bioaobo.com.
Statements made in this press release are forward-looking and are made
pursuant to the safe harbor provisions of the Securities Litigation Reform
Act of 1995. Such statements involve risks and uncertainties that may cause
actual results to differ materially from those set forth in these
statements. The economic, competitive, governmental, technological and
other factors identified in the Company's filings with the Securities and
Exchange Commission, including the Form 10-K for the year ended December
31, 2007, may cause actual results or events to differ materially from
|SOURCE American Oriental Bioengineering, Inc.|
Copyright©2008 PR Newswire.
All rights reserved